What are the prospects for genetically engineered, disease resistant plants?

Research output: Chapter in Book/Report/Conference proceeding › Book chapter › Research › peer-review

Standard

What are the prospects for genetically engineered, disease resistant plants? / Collinge, David B.; Lund, Ole Søgaard; Thordal-Christensen, Hans.

Sustainable disease management in a European context. Springer, 2008. p. 217-231.

Research output: Chapter in Book/Report/Conference proceeding › Book chapter › Research › peer-review

Harvard

Collinge, DB, Lund, OS & Thordal-Christensen, H 2008, What are the prospects for genetically engineered, disease resistant plants? in Sustainable disease management in a European context. Springer, pp. 217-231. https://doi.org/10.1007/978-1-4020-8780-6_2

APA

Collinge, D. B., Lund, O. S., & Thordal-Christensen, H. (2008). What are the prospects for genetically engineered, disease resistant plants? In Sustainable disease management in a European context (pp. 217-231). Springer. https://doi.org/10.1007/978-1-4020-8780-6_2

Vancouver

Collinge DB, Lund OS, Thordal-Christensen H. What are the prospects for genetically engineered, disease resistant plants? In Sustainable disease management in a European context. Springer. 2008. p. 217-231 https://doi.org/10.1007/978-1-4020-8780-6_2

Author

Collinge, David B. ; Lund, Ole Søgaard ; Thordal-Christensen, Hans. / What are the prospects for genetically engineered, disease resistant plants?. Sustainable disease management in a European context. Springer, 2008. pp. 217-231

Bibtex

@inbook{2840cbdb864949778955add38fe97d93,
title = "What are the prospects for genetically engineered, disease resistant plants?",
abstract = "Insect and herbicide-resistant plants are the most widely grown transgenics in agricultural production. No strategy using genetically engineered plants for disease resistance has had a comparable impact. Why is this? What are the prospects for introducing transgenic disease resistant plants to agriculture? We review the biological background for strategies used to make disease resistant GM crops, illustrate examples of these different strategies and discuss future prospects.",
keywords = "Bacterial disease, Disease resistant plants, Fungal disease, Genetically engineering, Plant virus",
author = "Collinge, {David B.} and Lund, {Ole S{\o}gaard} and Hans Thordal-Christensen",
year = "2008",
doi = "10.1007/978-1-4020-8780-6_2",
language = "English",
isbn = "9781402087790",
pages = "217--231",
booktitle = "Sustainable disease management in a European context",
publisher = "Springer",
address = "Switzerland",

}

RIS

TY - CHAP

T1 - What are the prospects for genetically engineered, disease resistant plants?

AU - Collinge, David B.

AU - Lund, Ole Søgaard

AU - Thordal-Christensen, Hans

PY - 2008

Y1 - 2008

N2 - Insect and herbicide-resistant plants are the most widely grown transgenics in agricultural production. No strategy using genetically engineered plants for disease resistance has had a comparable impact. Why is this? What are the prospects for introducing transgenic disease resistant plants to agriculture? We review the biological background for strategies used to make disease resistant GM crops, illustrate examples of these different strategies and discuss future prospects.

AB - Insect and herbicide-resistant plants are the most widely grown transgenics in agricultural production. No strategy using genetically engineered plants for disease resistance has had a comparable impact. Why is this? What are the prospects for introducing transgenic disease resistant plants to agriculture? We review the biological background for strategies used to make disease resistant GM crops, illustrate examples of these different strategies and discuss future prospects.

KW - Bacterial disease

KW - Disease resistant plants

KW - Fungal disease

KW - Genetically engineering

KW - Plant virus

U2 - 10.1007/978-1-4020-8780-6_2

DO - 10.1007/978-1-4020-8780-6_2

M3 - Book chapter

AN - SCOPUS:84900885927

SN - 9781402087790

SP - 217

EP - 231

BT - Sustainable disease management in a European context

PB - Springer

ER -

ID: 201511092